USCAP Specialty Conference: case 3.
Coffin
Cheryl M
CM
Department of Pathology, Division of Pediatric Pathology, Primary Children's Hospital, 100 North Medical Drive, Salt Lake City, UT 84113-1100, USA. pcccoffi@ihc.com
D015119:Aminocaproic Acid / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000378:metabolism; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006390:Hemangioendothelioma / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D018324:Hemangioma, Capillary / Q000175:diagnosis; D006801:Humans; D007150:Immunohistochemistry; D007223:Infant; D015552:Injections, Intralesional; D007372:Interferons / Q000627:therapeutic use; D012514:Sarcoma, Kaposi / Q000175:diagnosis; D012983:Soft Tissue Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D016896:Treatment Outcome; D014750:Vincristine / Q000627:therapeutic use
D000933:Antifibrinolytic Agents; D014408:Biomarkers, Tumor; D005938:Glucocorticoids; D014750:Vincristine; D007372:Interferons; D015119:Aminocaproic Acid